• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

各种最大似然非线性混合效应估计方法在剂量反应模型中的性能比较。

Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.

机构信息

Department of Pharmaceutical Biosciences, Uppsala University, Sweden.

出版信息

AAPS J. 2012 Sep;14(3):420-32. doi: 10.1208/s12248-012-9349-2. Epub 2012 Apr 14.

DOI:10.1208/s12248-012-9349-2
PMID:22528503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3385815/
Abstract

Estimation methods for nonlinear mixed-effects modelling have considerably improved over the last decades. Nowadays, several algorithms implemented in different software are used. The present study aimed at comparing their performance for dose-response models. Eight scenarios were considered using a sigmoid E(max) model, with varying sigmoidicity and residual error models. One hundred simulated datasets for each scenario were generated. One hundred individuals with observations at four doses constituted the rich design and at two doses, the sparse design. Nine parametric approaches for maximum likelihood estimation were studied: first-order conditional estimation (FOCE) in NONMEM and R, LAPLACE in NONMEM and SAS, adaptive Gaussian quadrature (AGQ) in SAS, and stochastic approximation expectation maximization (SAEM) in NONMEM and MONOLIX (both SAEM approaches with default and modified settings). All approaches started first from initial estimates set to the true values and second, using altered values. Results were examined through relative root mean squared error (RRMSE) of the estimates. With true initial conditions, full completion rate was obtained with all approaches except FOCE in R. Runtimes were shortest with FOCE and LAPLACE and longest with AGQ. Under the rich design, all approaches performed well except FOCE in R. When starting from altered initial conditions, AGQ, and then FOCE in NONMEM, LAPLACE in SAS, and SAEM in NONMEM and MONOLIX with tuned settings, consistently displayed lower RRMSE than the other approaches. For standard dose-response models analyzed through mixed-effects models, differences were identified in the performance of estimation methods available in current software, giving material to modellers to identify suitable approaches based on an accuracy-versus-runtime trade-off.

摘要

在过去的几十年中,非线性混合效应建模的估计方法有了很大的改进。如今,不同软件中实现了几种算法。本研究旨在比较这些方法在剂量反应模型中的性能。使用 sigmoid E(max)模型,考虑了 8 种不同的情况,其 sigmoidicity 和残差模型有所不同。为每种情况生成了 100 个模拟数据集。每个个体有 4 个剂量的观测值组成丰富设计,2 个剂量的观测值组成稀疏设计。研究了 9 种用于最大似然估计的参数方法:NONMEM 和 R 中的一阶条件估计(FOCE)、NONMEM 和 SAS 中的拉普拉斯(LAPLACE)、SAS 中的自适应高斯求积(AGQ)以及 NONMEM 和 MONOLIX 中的随机逼近期望最大化(SAEM)(这两种 SAEM 方法都有默认和修改的设置)。所有方法首先从设置为真实值的初始估计值开始,其次,从修改后的初始值开始。结果通过估计值的相对均方根误差(RRMSE)进行检查。在使用真实初始条件时,除了 R 中的 FOCE 之外,所有方法都能获得完整的完成率。FOCE 和 LAPLACE 的运行时间最短,而 AGQ 的运行时间最长。在丰富设计下,除了 R 中的 FOCE 之外,所有方法的表现都很好。当从修改后的初始条件开始时,AGQ、然后是 NONMEM 中的 FOCE、SAS 中的 LAPLACE、以及经过调整设置的 NONMEM 和 MONOLIX 中的 SAEM,始终显示出比其他方法更低的 RRMSE。对于通过混合效应模型分析的标准剂量反应模型,可用于当前软件的估计方法的性能存在差异,为建模者提供了根据准确性与运行时间的权衡来识别合适方法的依据。

相似文献

1
Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose-response models.各种最大似然非线性混合效应估计方法在剂量反应模型中的性能比较。
AAPS J. 2012 Sep;14(3):420-32. doi: 10.1208/s12248-012-9349-2. Epub 2012 Apr 14.
2
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.
3
Evaluation of estimation methods and power of tests of discrete covariates in repeated time-to-event parametric models: application to Gaucher patients treated by imiglucerase.评价离散协变量在重复时间事件参数模型中的估计方法和检验功效:以伊米苷酶治疗戈谢病患者为例。
AAPS J. 2014 May;16(3):415-23. doi: 10.1208/s12248-014-9575-x. Epub 2014 Feb 26.
4
Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.比较NONMEM中一阶条件估计(FOCE)和不同期望最大化(EM)方法的性能:复杂非线性母体-代谢物药代动力学模型的真实数据经验。
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):581-595. doi: 10.1007/s10928-021-09753-0. Epub 2021 Apr 21.
5
Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM Across Rich, Medium, and Sparse Sampling Data.使用NONMEM在丰富、中等和稀疏采样数据的群体药代动力学分析中对FOCEI和SAEM估计方法的评估
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):729-736. doi: 10.1007/s13318-018-0484-8.
6
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.非线性混合效应多响应模型的费希尔信息矩阵:使用药代动力学/药效学模型评估一阶线性化的适用性
Stat Med. 2009 Jun 30;28(14):1940-56. doi: 10.1002/sim.3573.
7
Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.比较FOCE与不同期望最大化方法在处理复杂群体生理药代动力学模型方面的性能。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):359-70. doi: 10.1007/s10928-016-9476-y. Epub 2016 May 23.
8
Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7.NONMEM 7 中估计方法的偏差、精度、稳健性和运行时间评估
J Pharmacokinet Pharmacodyn. 2014 Jun;41(3):223-38. doi: 10.1007/s10928-014-9359-z. Epub 2014 May 7.
9
Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.从样本量较小的数据集估计总体参数及其分布的一阶条件估计与交互和贝叶斯估计方法的性能比较。
BMC Med Res Methodol. 2017 Dec 1;17(1):154. doi: 10.1186/s12874-017-0427-0.
10
Performance in population models for count data, part II: a new SAEM algorithm.计数数据总体模型中的性能,第二部分:一种新的SAEM算法。
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):367-79. doi: 10.1007/s10928-009-9127-7. Epub 2009 Aug 13.

引用本文的文献

1
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases.健康志愿者和免疫炎症性疾病患者口服布雷替尼的群体药代动力学建模。
CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):551-562. doi: 10.1002/psp4.13100. Epub 2024 Feb 8.
2
Evaluation of model-based bioequivalence approach for single sample pharmacokinetic studies.基于模型的单样本药代动力学研究生物等效性评价方法。
CPT Pharmacometrics Syst Pharmacol. 2023 Jul;12(7):904-915. doi: 10.1002/psp4.12960. Epub 2023 Apr 27.
3
Simulation-Based Pharmacokinetics Sampling Design for Evaluating Correlates of Prevention Efficacy of Passive HIV Monoclonal Antibody Prophylaxis.基于模拟的药代动力学采样设计,用于评估被动式HIV单克隆抗体预防的预防效果相关性
Stat Biopharm Res. 2022;14(4):611-625. doi: 10.1080/19466315.2021.1919196. Epub 2021 Jun 28.
4
Predicting Antibiotic Effect of Vancomycin Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation: Dense Sampling versus Sparse Sampling.使用药代动力学/药效学建模与模拟预测万古霉素的抗生素效应:密集采样与稀疏采样
Antibiotics (Basel). 2022 May 31;11(6):743. doi: 10.3390/antibiotics11060743.
5
Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.比较NONMEM中一阶条件估计(FOCE)和不同期望最大化(EM)方法的性能:复杂非线性母体-代谢物药代动力学模型的真实数据经验。
J Pharmacokinet Pharmacodyn. 2021 Aug;48(4):581-595. doi: 10.1007/s10928-021-09753-0. Epub 2021 Apr 21.
6
Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.贝叶斯个体动态预测与纵向生物标志物不确定性和生存事件风险在联合建模框架中:Stan、Monolix 和 NONMEM 之间的比较。
AAPS J. 2020 Feb 19;22(2):50. doi: 10.1208/s12248-019-0388-9.
7
Evaluation of FOCEI and SAEM Estimation Methods in Population Pharmacokinetic Analysis Using NONMEM Across Rich, Medium, and Sparse Sampling Data.使用NONMEM在丰富、中等和稀疏采样数据的群体药代动力学分析中对FOCEI和SAEM估计方法的评估
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):729-736. doi: 10.1007/s13318-018-0484-8.
8
Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.从样本量较小的数据集估计总体参数及其分布的一阶条件估计与交互和贝叶斯估计方法的性能比较。
BMC Med Res Methodol. 2017 Dec 1;17(1):154. doi: 10.1186/s12874-017-0427-0.
9
Comparing the performance of FOCE and different expectation-maximization methods in handling complex population physiologically-based pharmacokinetic models.比较FOCE与不同期望最大化方法在处理复杂群体生理药代动力学模型方面的性能。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):359-70. doi: 10.1007/s10928-016-9476-y. Epub 2016 May 23.
10
Using the SAEM algorithm for mechanistic joint models characterizing the relationship between nonlinear PSA kinetics and survival in prostate cancer patients.使用SAEM算法构建机械性联合模型,以表征前列腺癌患者非线性前列腺特异性抗原动力学与生存率之间的关系。
Biometrics. 2017 Mar;73(1):305-312. doi: 10.1111/biom.12537. Epub 2016 May 5.

本文引用的文献

1
Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model.基于目标介导药物处置模型的非隔室分析 7.2 版估计方法比较与并行处理效率评估。
J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):17-35. doi: 10.1007/s10928-011-9228-y. Epub 2011 Nov 19.
2
Development of a complex parent-metabolite joint population pharmacokinetic model.开发复杂的母体-代谢物联合群体药代动力学模型。
AAPS J. 2011 Sep;13(3):390-404. doi: 10.1208/s12248-011-9282-9. Epub 2011 May 27.
3
The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.利用 MONOLIX 软件中的 SAEM 算法估算无症状 HIV 受试者中马拉维若的群体药代动力学-药效学-病毒动力学参数。
J Pharmacokinet Pharmacodyn. 2011 Feb;38(1):41-61. doi: 10.1007/s10928-010-9175-z. Epub 2010 Nov 19.
4
Implementation and evaluation of the SAEM algorithm for longitudinal ordered categorical data with an illustration in pharmacokinetics-pharmacodynamics.实施和评估用于纵向有序分类数据的 SAEM 算法,并在药代动力学-药效学中进行说明。
AAPS J. 2011 Mar;13(1):44-53. doi: 10.1208/s12248-010-9238-5. Epub 2010 Nov 11.
5
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.多响应非线性混合效应模型中的设计评估与优化:PFIM 3.0。
Comput Methods Programs Biomed. 2010 Apr;98(1):55-65. doi: 10.1016/j.cmpb.2009.09.012. Epub 2009 Nov 4.
6
Performance in population models for count data, part II: a new SAEM algorithm.计数数据总体模型中的性能,第二部分:一种新的SAEM算法。
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):367-79. doi: 10.1007/s10928-009-9127-7. Epub 2009 Aug 13.
7
Performance in population models for count data, part I: maximum likelihood approximations.计数数据总体模型中的性能,第一部分:最大似然近似。
J Pharmacokinet Pharmacodyn. 2009 Aug;36(4):353-66. doi: 10.1007/s10928-009-9126-8. Epub 2009 Aug 4.
8
Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.群体药代动力学/药效学分析中模型构建策略概述:2002 - 2004年文献调查
Br J Clin Pharmacol. 2007 Nov;64(5):603-12. doi: 10.1111/j.1365-2125.2007.02975.x. Epub 2007 Aug 15.
9
Derivation of various NONMEM estimation methods.各种NONMEM估计方法的推导。
J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):575-93. doi: 10.1007/s10928-007-9060-6. Epub 2007 Jul 10.
10
A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.复杂药代动力学和药效学模型的群体分析方法及软件综述,并附实例
AAPS J. 2007 Mar 2;9(1):E60-83. doi: 10.1208/aapsj0901007.